Biocept Ownership 2024 | Who Owns Biocept Now?

OverviewChart

Institutional Ownership

0.36%

Insider Ownership

9.21%

Retail Ownership

90.43%

Institutional Holders

17.00

Biocept Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
RENAISSANCE TECHNOLOGIES LLC	1.14%	0.00%	193,741	31,441	19.37%	66,000	Mar 31, 2023
BLACKROCK INC.	0.93%	-	157,913	-	-	53,690,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	0.79%	-	134,112	-3,386	-2.46%	45,598,000	Mar 31, 2023
BRIDGEWAY CAPITAL MANAGEMENT, LLC	0.56%	0.00%	94,200	-15,236	-13.92%	32,028,000	Mar 31, 2023
HRT FINANCIAL LP	0.33%	0.00%	55,334	55,334	100.00%	18,000	Mar 31, 2023
STATE STREET CORP	0.24%	-	40,596	-	-	13,803,000	Mar 31, 2023
SABBY MANAGEMENT, LLC	0.17%	0.01%	29,602	-900	-2.95%	10,065,000	Mar 31, 2023
NORTHERN TRUST CORP	0.16%	-	26,818	-	-	9,118,000	Mar 31, 2023
TAYLOR & MORGAN WEALTH MANAGEMENT, LLC	0.15%	0.01%	26,000	-	-	8,840,000	Mar 31, 2023
JANE STREET GROUP, LLC	0.15%	-	25,403	25,403	100.00%	8,637,000	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.13%	-	22,477	10,331	85.06%	7,642,000	Mar 31, 2023
ERGOTELES LLC	0.13%	0.00%	22,020	22,020	100.00%	7,487,000	Mar 31, 2023
ACADIAN ASSET MANAGEMENT LLC	0.08%	-	13,871	-	-	4,000	Mar 31, 2023
AMERIPRISE FINANCIAL INC	0.07%	-	11,602	-673	-5.48%	3,945,000	Mar 31, 2023
GOLDMAN SACHS GROUP INC	0.06%	-	10,903	10,903	100.00%	3,707,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.05%	0.00%	8,369	-17	-0.20%	3,000	Mar 31, 2023
CITADEL ADVISORS LLC	0.05%	-	8,209	-2,187	-21.04%	2,791,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	0.05%	-	8,000	7,190	887.65%	2,720,000	Mar 31, 2023
CITADEL ADVISORS LLC	0.03%	-	4,800	-34,600	-87.82%	1,632,000	Mar 31, 2023
UBS GROUP AG	0.03%	-	4,412	-3,815	-46.37%	1,500,000	Mar 31, 2023

Biocept's largest institutional shareholder is RENAISSANCE TECHNOLOGIES LLC, holding 1.14% of the company's total share outstanding, currently valued at $66.00K. The top 10 institutional shareholders own together 4.62% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SABBY MANAGEMENT, LLC	0.17%	0.01%	29,602	-900	-2.95%	10,065,000	Mar 31, 2023
TAYLOR & MORGAN WEALTH MANAGEMENT, LLC	0.15%	0.01%	26,000	-	-	8,840,000	Mar 31, 2023
BRIDGEWAY CAPITAL MANAGEMENT, LLC	0.56%	0.00%	94,200	-15,236	-13.92%	32,028,000	Mar 31, 2023
ERGOTELES LLC	0.13%	0.00%	22,020	22,020	100.00%	7,487,000	Mar 31, 2023
HRT FINANCIAL LP	0.33%	0.00%	55,334	55,334	100.00%	18,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.05%	0.00%	8,369	-17	-0.20%	3,000	Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC	1.14%	0.00%	193,741	31,441	19.37%	66,000	Mar 31, 2023
ACADIAN ASSET MANAGEMENT LLC	0.08%	-	13,871	-	-	4,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	0.05%	-	8,000	7,190	887.65%	2,720,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	0.79%	-	134,112	-3,386	-2.46%	45,598,000	Mar 31, 2023
JANE STREET GROUP, LLC	0.15%	-	25,403	25,403	100.00%	8,637,000	Mar 31, 2023
NORTHERN TRUST CORP	0.16%	-	26,818	-	-	9,118,000	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.13%	-	22,477	10,331	85.06%	7,642,000	Mar 31, 2023
BLACKROCK INC.	0.93%	-	157,913	-	-	53,690,000	Mar 31, 2023
AMERIPRISE FINANCIAL INC	0.07%	-	11,602	-673	-5.48%	3,945,000	Mar 31, 2023
GOLDMAN SACHS GROUP INC	0.06%	-	10,903	10,903	100.00%	3,707,000	Mar 31, 2023
STATE STREET CORP	0.24%	-	40,596	-	-	13,803,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.01%	-	1,000	-1,000	-50.00%	340,000	Mar 31, 2023
CITADEL ADVISORS LLC	0.05%	-	8,209	-2,187	-21.04%	2,791,000	Mar 31, 2023
UBS GROUP AG	0.03%	-	4,412	-3,815	-46.37%	1,500,000	Mar 31, 2023

The largest Biocept shareholder by % of total assets is SABBY MANAGEMENT, LLC. The company owns 29.60K shares of Biocept (BIOC), representing 0.01% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
HRT FINANCIAL LP	0.33%	0.00%	55,334	55,334	100.00%	18,000	Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC	1.14%	0.00%	193,741	31,441	19.37%	66,000	Mar 31, 2023
JANE STREET GROUP, LLC	0.15%	-	25,403	25,403	100.00%	8,637,000	Mar 31, 2023
ERGOTELES LLC	0.13%	0.00%	22,020	22,020	100.00%	7,487,000	Mar 31, 2023
GOLDMAN SACHS GROUP INC	0.06%	-	10,903	10,903	100.00%	3,707,000	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.13%	-	22,477	10,331	85.06%	7,642,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	0.05%	-	8,000	7,190	887.65%	2,720,000	Mar 31, 2023
FMR LLC	0.00%	-	20	20	100.00%	7,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	118	2	1.72%	40,000	Mar 31, 2023
ROYAL BANK OF CANADA	0.02%	-	3,487	-	-	1,000,000	Mar 31, 2023
US BANCORP \DE\	0.00%	-	583	-	-	198,000	Mar 31, 2023
STATE STREET CORP	0.24%	-	40,596	-	-	13,803,000	Mar 31, 2023
BLACKROCK INC.	0.93%	-	157,913	-	-	53,690,000	Mar 31, 2023
NORTHERN TRUST CORP	0.16%	-	26,818	-	-	9,118,000	Mar 31, 2023
ACADIAN ASSET MANAGEMENT LLC	0.08%	-	13,871	-	-	4,000	Mar 31, 2023
TAYLOR & MORGAN WEALTH MANAGEMENT, LLC	0.15%	0.01%	26,000	-	-	8,840,000	Mar 31, 2023
FOCUSED WEALTH MANAGEMENT, INC	-	-	-	-1	-100.00%	-	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.05%	0.00%	8,369	-17	-0.20%	3,000	Mar 31, 2023
CITADEL ADVISORS LLC	0.00%	-	100	-100	-50.00%	34,000	Mar 31, 2023
BANK OF AMERICA CORP /DE/	-	-	-	-540	-100.00%	-	Mar 31, 2023

As of Mar 31 2023, Biocept's largest institutional buyer is HRT FINANCIAL LP. The company purchased 55.33K stocks of BIOC, valued at $18.00K.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
VANGUARD GROUP INC	-	-	-	-617,984	-100.00%	-	Mar 31, 2023
CITADEL ADVISORS LLC	0.03%	-	4,800	-34,600	-87.82%	1,632,000	Mar 31, 2023
VIRTU FINANCIAL LLC	-	-	-	-23,001	-100.00%	-	Mar 31, 2023
SIMPLEX TRADING, LLC	-	-	-	-20,500	-100.00%	-	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	-	-	-	-16,200	-100.00%	-	Mar 31, 2023
BRIDGEWAY CAPITAL MANAGEMENT, LLC	0.56%	0.00%	94,200	-15,236	-13.92%	32,028,000	Mar 31, 2023
CWM, LLC	-	-	-	-11,200	-100.00%	-	Mar 31, 2023
UBS GROUP AG	0.03%	-	4,412	-3,815	-46.37%	1,500,000	Mar 31, 2023
SIMPLEX TRADING, LLC	-	-	-	-3,768	-100.00%	-	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	0.79%	-	134,112	-3,386	-2.46%	45,598,000	Mar 31, 2023
CITADEL ADVISORS LLC	0.05%	-	8,209	-2,187	-21.04%	2,791,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.01%	-	1,000	-1,000	-50.00%	340,000	Mar 31, 2023
SABBY MANAGEMENT, LLC	0.17%	0.01%	29,602	-900	-2.95%	10,065,000	Mar 31, 2023
AMERIPRISE FINANCIAL INC	0.07%	-	11,602	-673	-5.48%	3,945,000	Mar 31, 2023
BANK OF AMERICA CORP /DE/	-	-	-	-540	-100.00%	-	Mar 31, 2023
CITADEL ADVISORS LLC	0.00%	-	100	-100	-50.00%	34,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.05%	0.00%	8,369	-17	-0.20%	3,000	Mar 31, 2023
FOCUSED WEALTH MANAGEMENT, INC	-	-	-	-1	-100.00%	-	Mar 31, 2023
TAYLOR & MORGAN WEALTH MANAGEMENT, LLC	0.15%	0.01%	26,000	-	-	8,840,000	Mar 31, 2023
ACADIAN ASSET MANAGEMENT LLC	0.08%	-	13,871	-	-	4,000	Mar 31, 2023

As of Mar 31 2023, Biocept's biggest institutional seller is VANGUARD GROUP INC. The company sold -0.62M shares of BIOC, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
HRT FINANCIAL LP	0.33%	0.00%	55,334	55,334	100.00%	18,000	Mar 31, 2023
JANE STREET GROUP, LLC	0.15%	-	25,403	25,403	100.00%	8,637,000	Mar 31, 2023
ERGOTELES LLC	0.13%	0.00%	22,020	22,020	100.00%	7,487,000	Mar 31, 2023
GOLDMAN SACHS GROUP INC	0.06%	-	10,903	10,903	100.00%	3,707,000	Mar 31, 2023
FMR LLC	0.00%	-	20	20	100.00%	7,000	Mar 31, 2023

Biocept's largest new institutional shareholder by number of shares is HRT FINANCIAL LP, purchased 55.33K shares, valued at $18.00K, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
VANGUARD GROUP INC	-	-	-	-617,984	-100.00%	-	Mar 31, 2023
VIRTU FINANCIAL LLC	-	-	-	-23,001	-100.00%	-	Mar 31, 2023
SIMPLEX TRADING, LLC	-	-	-	-20,500	-100.00%	-	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	-	-	-	-16,200	-100.00%	-	Mar 31, 2023
CWM, LLC	-	-	-	-11,200	-100.00%	-	Mar 31, 2023
SIMPLEX TRADING, LLC	-	-	-	-3,768	-100.00%	-	Mar 31, 2023
BANK OF AMERICA CORP /DE/	-	-	-	-540	-100.00%	-	Mar 31, 2023
FOCUSED WEALTH MANAGEMENT, INC	-	-	-	-1	-100.00%	-	Mar 31, 2023

Biocept's largest sold out institutional shareholder by shares sold is VANGUARD GROUP INC, sold -0.62M shares, valued at -, as of undefined.

Biocept Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
BRIDGEWAY FUNDS INC	0.04%	94,200	-	-	Mar 28, 2024
HUSSMAN INVESTMENT TRUST	0.02%	72,000	-	-	Dec 31, 2023
VANGUARD INDEX FUNDS	0.02%	6,422,826	-	-	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	801,006	-	-	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	612,643	-	-	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	129,601	-	-	Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	8,656	-	-	Mar 31, 2024
USAA MUTUAL FUNDS TRUST	0.00%	22,043	-	-	Jan 31, 2024
NATIONWIDE MUTUAL FUNDS	0.00%	9,325	-	-	Jan 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	4,273	-	-	Feb 29, 2024
DFA INVESTMENT DIMENSIONS GROUP INC	0.00%	18,363	-	-	Jan 31, 2024
VANGUARD INDEX FUNDS	0.00%	4,434	-	-	Mar 31, 2024
USAA MUTUAL FUNDS TRUST	0.00%	1,920	-	-	Jan 31, 2024
Dimensional ETF Trust	0.00%	2,200	-	-	Jan 31, 2024
EQ ADVISORS TRUST	0.00%	2,888	-	-	Mar 31, 2024

Biocept's largest mutual fund holder by % of total assets is "BRIDGEWAY FUNDS INC", owning 94.20K shares, compromising 0.04% of its total assets.

Biocept Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 20	17	13.33%
31 Mar, 20	15	15.38%
31 Dec, 19	13	18.18%
30 Sep, 19	11	10.00%
30 Jun, 19	10	-37.50%
31 Mar, 19	16	45.45%
31 Dec, 18	11	57.14%
30 Sep, 18	7	250.00%
30 Jun, 18	2	-

As of 30 Jun 20, 17 institutions are holding Biocept's shares, representing an increase of 13.33% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 20	13,704,608	342.00%
31 Mar, 20	3,100,601	201.37%
31 Dec, 19	1,028,825	177.30%
30 Sep, 19	371,013	1.49%
30 Jun, 19	365,572	-17.32%
31 Mar, 19	442,130	33.13%
31 Dec, 18	332,114	40.03%
30 Sep, 18	237,168	-0.46%
30 Jun, 18	238,268	-

Biocept (BIOC) has 13.70M shares outstanding as of 30 Jun 20, up 342.00% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 20	0.36%	2099.16%
31 Mar, 20	0.13%	6944.01%
31 Dec, 19	0.04%	17662.42%
30 Sep, 19	0.02%	6590.26%
30 Jun, 19	0.02%	4421.39%
31 Mar, 19	0.02%	9509.29%
31 Dec, 18	0.01%	14003.00%
30 Sep, 18	0.01%	9953833.33%
30 Jun, 18	0.00%	-

As of 30 Jun 20, Biocept is held by 0.36% institutional shareholders, representing a 2099.16% growth compared to 31 Mar 20.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 20	13	18.18%
31 Mar, 20	11	22.22%
31 Dec, 19	9	125.00%
30 Sep, 19	4	33.33%
30 Jun, 19	3	-76.92%
31 Mar, 19	13	62.50%
31 Dec, 18	8	14.29%
30 Sep, 18	7	250.00%
30 Jun, 18	2	-

13 institutional shareholders have increased their position in BIOC stock as of 30 Jun 20 compared to 11 in the previous quarter (a 18.18% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 20	1	-
31 Mar, 20	1	-
31 Dec, 19	-	-100.00%
30 Sep, 19	1	-
30 Jun, 19	1	-
31 Mar, 19	1	-50.00%
31 Dec, 18	2	-
30 Sep, 18	-	-
30 Jun, 18	-	-

1 institutional shareholders have reduced their position in BIOC stock as of 30 Jun 20 compared to 1 in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 20	17	13.33%	13,704,608	342.00%	0.36%	2099.16%	13	18.18%	1	-
31 Mar, 20	15	15.38%	3,100,601	201.37%	0.13%	6944.01%	11	22.22%	1	-
31 Dec, 19	13	18.18%	1,028,825	177.30%	0.04%	17662.42%	9	125.00%	-	-100.00%
30 Sep, 19	11	10.00%	371,013	1.49%	0.02%	6590.26%	4	33.33%	1	-
30 Jun, 19	10	-37.50%	365,572	-17.32%	0.02%	4421.39%	3	-76.92%	1	-
31 Mar, 19	16	45.45%	442,130	33.13%	0.02%	9509.29%	13	62.50%	1	-50.00%
31 Dec, 18	11	57.14%	332,114	40.03%	0.01%	14003.00%	8	14.29%	2	-
30 Sep, 18	7	250.00%	237,168	-0.46%	0.01%	9953833.33%	7	250.00%	-	-
30 Jun, 18	2	-	238,268	-	0.00%	-	2	-	-	-

Biocept Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Dec 10, 2021	HALE DAVID F	director	-	S-Sale	Sell	363	$4.06	$1.47K	3,114
Dec 10, 2021	HALE DAVID F	director	-	S-Sale	Sell	71	$4.07	$288.71	796

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jun 20, 2023	Walsh Robert	officer	VP, Controller		Sell	806	$30.90	$24.91K	-
Dec 10, 2021	HALE DAVID F	director	-	S-Sale	Sell	363	$4.06	$1.47K	3,114
Dec 10, 2021	HALE DAVID F	director	-	S-Sale	Sell	71	$4.07	$288.71	796

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jun 20, 2023	Walsh Robert	officer	VP, Controller		Sell	806	$30.90	$24.91K	-
Nov 18, 2022	DAO-HADDOCK QUYEN THI	director	-	A-Award	Buy	10,000	-	-	10,000
Nov 18, 2022	DAO-HADDOCK QUYEN THI	-	-		Buy	-	-	-	-
Nov 18, 2022	DAO-HADDOCK QUYEN THI	director			Buy	-	-	-	-
Sep 08, 2022	Chandler Marsha Alpert	director		A-Award	Buy	10,000	-	-	10,000
Sep 08, 2022	Chandler Marsha Alpert	director	-	A-Award	Buy	10,000	$1.03	$10.30K	10,000
Sep 08, 2022	Rubinstein Linda M	director		A-Award	Buy	10,000	-	-	10,000
Sep 08, 2022	Gerhardt Bruce	director		A-Award	Buy	10,000	-	-	10,000
Sep 08, 2022	ROYSTON IVOR	director		A-Award	Buy	10,000	-	-	10,000
Sep 08, 2022	ROYSTON IVOR	director	-	A-Award	Buy	10,000	$1.03	$10.30K	10,000
Sep 08, 2022	Wilson Margaret Faye	director		A-Award	Buy	10,000	-	-	10,000
Apr 04, 2022	Taylor Darrell	officer	See remarks	A-Award	Buy	15,450	-	-	15,450
Apr 04, 2022	Marchand Philippe	officer	Chief Operations Officer	A-Award	Buy	150,000	-	-	150,000
Mar 16, 2022	Marchand Philippe	officer	-		Buy	-	-	-	-
Mar 16, 2022	Taylor Darrell	officer	Sr. V.P., General Counsel	A-Award	Buy	134,550	$2.39	$321.57K	134,550
Mar 16, 2022	Taylor Darrell	officer	-		Buy	-	-	-	-
Mar 02, 2022	Riccitelli Samuel D	director, officer	Interim President and CEO	A-Award	Buy	250,000	$2.39	$597.50K	250,000
Mar 02, 2022	Morales Antonino	director, officer	Interim CFO	A-Award	Buy	150,000	$2.39	$358.50K	150,000
Dec 10, 2021	HALE DAVID F	director	-	S-Sale	Sell	363	$4.06	$1.47K	3,114
Dec 10, 2021	HALE DAVID F	director	-	S-Sale	Sell	71	$4.07	$288.71	796

The last insider sell of Biocept's stock was made by Walsh Robert on Jun 20 2023, selling 806 shares at $30.90 per share (valued at $24.91K).

Biocept Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q4 2022	1	-	-
Q3 2022	5	-	-
Q1 2022	5	-	-
Q4 2021	-	3	-
Q3 2021	13	2	650.00%
Q4 2020	5	-	-
Q3 2020	1	1	100.00%
Q2 2020	6	3	200.00%
Q1 2020	-	3	-
Q2 2019	17	-	-
Q3 2018	1	-	-
Q2 2018	6	-	-
Q1 2018	2	-	-
Q3 2017	-	2	-
Q2 2017	15	-	-
Q1 2017	11	4	275.00%
Q4 2016	22	2	1100.00%
Q3 2016	5	-	-
Q2 2016	9	1	900.00%
Q1 2016	6	1	600.00%

1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Biocept's insiders, as of Q4 2022.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q4 2022	-	-	-
Q3 2022	-	-	-
Q1 2022	-	-	-
Q4 2021	-	3	-
Q3 2021	-	-	-
Q4 2020	-	-	-
Q3 2020	-	-	-
Q2 2020	-	3	-
Q1 2020	-	-	-
Q2 2019	-	-	-
Q3 2018	-	-	-
Q2 2018	-	-	-
Q1 2018	2	-	-
Q3 2017	-	-	-
Q2 2017	-	-	-
Q1 2017	-	-	-
Q4 2016	22	-	-
Q3 2016	-	-	-
Q2 2016	8	-	-
Q1 2016	-	-	-

As of Q4 2022, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Biocept's stocks.

Biocept Peer Ownership

Ticker	Company
AYTU	Aytu BioPharma, Inc.
DFFN	CervoMed Inc.
ONTX	Traws Pharma, Inc.

BIOC Ownership FAQ

Who Owns Biocept?

Biocept is owned by institutional shareholders (0.36%), insiders (9.21%), and public (90.43%). The largest institutional shareholder of Biocept is RENAISSANCE TECHNOLOGIES LLC (1.14% of total shares) and the top mutual fund owner is BRIDGEWAY FUNDS INC (0.04% of total shares).

Who are the major institutional shareholders of Biocept?

Biocept's major institutional shareholders are RENAISSANCE TECHNOLOGIES LLC, BLACKROCK INC., GEODE CAPITAL MANAGEMENT, LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, and HRT FINANCIAL LP. The top five shareholders own together 3.75% of the company's share outstanding.

How many Biocept shareholders are there?

As of Jun 2020, there are 17 institutional shareholders of Biocept.

What percentage of Biocept is owned by RENAISSANCE TECHNOLOGIES LLC?

RENAISSANCE TECHNOLOGIES LLC owns 193.74K shares of Biocept, representing 1.14% of the company's total shares outstanding, valued at $66K (as of Mar 2023).

What percentage of Biocept is owned by BLACKROCK INC?

As of Mar 2023, BLACKROCK INC holds 157.91K shares of Biocept (BIOC), compromising 0.93% of the company, valued at $53.69M.

What percentage of Biocept is owned by GEODE CAPITAL MANAGEMENT, LLC?

GEODE CAPITAL MANAGEMENT, LLC is the third largest holder of Biocept. The company owns 134.11K of the company's shares outstanding (worth $45.6M).